生命科学资讯

CareDx (CDNA) Is Up 9.4% After Strong 2025 Outlook And 10x Genomics Tie-Up - Has The Bull Case Changed? - Yahoo Finance

10x Genomics partners with Brigham & Women’s for autoimmune research By Investing.com - Investing.com Nigeria

Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG) - The Globe and Mail

Why 10x Genomics (TXG) Shares Are Falling Today - Finviz

Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG) - The Globe and Mail

Why 10x Genomics (TXG) Shares Are Falling Today - Yahoo Finance

Why 10x Genomics (TXG) Shares Are Falling Today - TradingView — Track All Markets

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - Yahoo Finance

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - PR Newswire

New study tracks blood signals to guide care for autoimmune disease patients - Stock Titan

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - Financial Times

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling - PR Newswire

10x Genomics Goes Clinical With Single-Cell Diagnostics At J.P. Morgan 2026 - Inside Precision Medicine

JPM 2026: 10x Genomics Goes Diagnostic, Aims Single-Cell to Clinical Application - Inside Precision Medicine

Balanced Risk/Reward Keeps 10x Genomics at Hold Despite Solid Execution and Discounted Valuation - TipRanks

10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus

10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha

10X Genomics Q4 prelim revenue beats on consumables unit strength - TradingView — Track All Markets

10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus

10x Genomics reports preliminary Q4 revenue $166M, consensus $155.95M - TipRanks